Article
Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.
PloS one - 1 Jan 2012
Zhuo Wenlei, Zhang Liang, Zhu Bo, Ling Junjun, Chen Zhengtang
Abstract excerpt
BACKGROUND: Evidence suggests that MDM2 T309G polymorphism may be a risk factor for several cancers. Increasing investigations have been conducted on the association of MDM2 T309G polymorphisms with lung cancer risk and have yielded conflicting results. Previous meta-analyses on this issue have reported inconclusive data. The aim of the present study was to derive a more precise estimation of the relationship....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
